|
Decapeptide-12
|
|
137665-91-9
|
|
Selank
|
|
129954-34-3
|
|
Sitagliptin Impurity 40 HCl
|
|
1374985-05-3
|
|
(3S,5S)-Pitavastatin Calcium Salt
|
|
254452-92-1
|
|
Atorvastatin Ethyl Ester
|
|
1146977-93-6
|
|
TM-5275 sodium salt
|
|
1103926-82-4
|
|
Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity
|
|
1315629-79-8
|
|
(Z)-Pitavastatin Calcium Salt
|
|
1159588-21-2
|
|
LY2109761
|
|
700874-71-1
|
|
7-Deaza-2'-C-methyladenosine
|
|
443642-29-3
|
|
JNJ-40411813
|
|
1127498-03-6
|
|
AY-NH2
|
|
352017-71-1
|
|
ACTH (18-39) (human)
|
|
53917-42-3
|
|
Laminin (925-933)
|
|
110590-60-8
|
|
Gap 26
|
|
197250-15-0
|
|
VKGILS-NH2
|
|
942413-05-0
|
|
CTOP
|
|
103429-31-8
|
|
Protease-Activated Receptor-2, amide
|
|
190383-13-2
|
|
Fangchinoline
|
|
436-77-1
|
|
MK-5172
|
|
1350514-68-9
|
|
2'-Deoxy-N4-methylcytidine
|
|
22882-02-6
|
|
Afatinib Impurity J
|
|
1456696-14-2
|
|
N4-benzoyl-5'-O-tert-Butyldimethylsilyl-2'-deoxycytidine
|
|
51549-36-1
|
|
1-Palmitoyl-2-hydroxy-sn-glycero-3-PC
|
|
17364-16-8
|
|
(2R,4S)-4-Amino-5-biphenyl-4-yl-2-methylpentanoic acid hydrochloride
|
|
1038924-71-8
|
|
Trospium Chloride
|
|
10405-02-4
|
|
GLP-1(7-37)
|
|
106612-94-6
|
|
N-Acetyl-L-seryl-D-α-aspartyl-L-lysyl-L-proline
|
|
127103-11-1
|
|
Lysipressin
|
|
50-57-7
|
|
Secretin Acetate
|
|
10813-74-8
|
|
Somatostatin
|
|
51110-01-1
|
|
Argipressin Acetate
|
|
129979-57-3
|
|
5-L-Isoleucineangiotensin II
|
|
4474-91-3
|
|
Desmopressin diacetate
|
|
16789-98-3
|
|
MOTS-C
|
|
1627580-64-6
|
|
Calcitonin eel
|
|
57014-02-5
|
|
LL-37, Human
|
|
154947-66-7
|
|
omega conotoxin MVIIA
|
|
107452-89-1
|
|
Deltasleep-inducing peptide
|
|
62568-57-4
|
|
RC 160
|
|
103222-11-3
|
|
ACTH 22-39
|
|
37548-29-1
|
|
ACTH 1-17
|
|
7266-47-9
|
|
N-Acetyl sulfadiazine
|
|
127-74-2
|
|
4-Hydroxy Duloxetine
|
|
662149-13-5
|
|
R788 disodium hexahydrate
|
|
914295-16-2
|
|
Brevilin A
|
|
16503-32-5
|
|
BMS303141
|
|
943962-47-8
|
|
Rubitecan
|
|
91421-42-0
|
|
ABT 724 trihydrochloride
|
|
587870-77-7
|
|
Methyl Olivetolate
|
|
58016-28-7
|
|
SB239063
|
|
193551-21-2
|
|
Sitagliptin EP Impurity C Phosphate
|
|
1345822-86-7
|
|
Efinaconazole Related Impurity 3
|
|
164650-45-7
|
|
Ethyl 2,4-dihydroxy-6-pentylbenzoate
|
|
38862-65-6
|
|
Bacoside A3
|
|
157408-08-7
|
|
DAF-2
|
|
205391-01-1
|
|
Ixazomib Citrate
|
|
1239908-20-3
|
|
GsMTx4
|
|
1209500-46-8
|
|
BKT140
|
|
664334-36-5
|
|
YAP-TEAD Inhibitor 1
|
|
1659305-78-8
|
|
ATI-2341
|
|
1337878-62-2
|
|
((Cys31,Nva34)-Neuropeptide Y (27-36))2
|
|
172997-92-1
|
|
ACTH (1-39), Porcine
|
|
9061-27-2
|
|
COG 133
|
|
514200-66-9
|
|
Dynorphin A (1-13)
|
|
72957-38-1
|
|
Amylin (human)
|
|
122384-88-7
|
|
PHM-27 (human)
|
|
87403-73-4
|
|
Gastrin I (human)
|
|
10047-33-3
|
|
Ansamitocin P-3
|
|
66584-72-3
|
|
mu-conotoxin
|
|
936616-33-0
|
|
Acetyl tetrapeptide-15
|
|
928007-64-1
|
|
Tetrapeptide-30
|
|
1036207-61-0
|
|
Nifuratel
|
|
4936-47-4
|
|
Irofulven
|
|
158440-71-2
|
|
Folic Acid EP Impurity C
|
|
47707-78-8
|
|
Palmitoyl hexapeptide-12
|
|
171263-26-6
|
|
Atpenin A5
|
|
119509-24-9
|
|
Transdermal Peptide
|
|
918629-48-8
|
|
Seletalisib
|
|
1362850-20-1
|
|
Cetirizine Glycerol Ester Impurity
|
|
1243652-36-9
|
|
RGD peptide
|
|
114681-65-1
|
|
Dynorphin A (1-8)
|
|
75790-53-3
|
|
DALARGIN
|
|
81733-79-1
|
|
Ac-WEHD-AFC
|
|
210344-99-3
|
|
Ethyl 2-[5-(4-methylpiperazinyl)benzimidazol-2-yl]acetate
|
|
402948-37-2
|
|
4'-Hydroxy Atomoxetine
|
|
435293-66-6
|
|
Nestoron
|
|
7759-35-5
|
|
Plerixafor Impurity III
|
|
771464-86-9
|
|
4-N-(3-Chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine
|
|
402855-03-2
|
|
N-(2-Chloro-1-oxopropyl)glycine
|
|
85038-45-5
|
|
Protease-Activated Receptor-2 Activating Peptide
|
|
171436-38-7
|
|
PAR-2 (1-6) (mouse, rat)
|
|
164081-25-8
|
|
PAR4 (1-6) (human)
|
|
225779-44-2
|
|
TFLLR-NH2
|
|
197794-83-5
|
|
Compstatin
|
|
206645-99-0
|
|
Ambroxol EP Impurity D HCl
|
|
1384955-66-1
|
|
TCID
|
|
30675-13-9
|
|
CJC1295 With DAC
|
|
446262-90-4
|
|
Hexapeptide-3
|
|
1205679-02-2
|
|
Berubicin
|
|
677017-23-1
|